Has Allison Williams received payments from drug or device companies?

Yes. Drug and device makers reported $2,199 in general payments to Allison Williams across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Allison Williams did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Allison Williams come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Allison Williams

Medical · Blairsville, PANPI 1821055799

Payments from drug & device makers

$2,199in general payments, 2019–2025

Across 129 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$707
Lilly USA, LLC$286
Novo Nordisk$240
Pfizer$156
Abbott$133
Merck$71
plus $607 from 19 others

What the payments were for

Food & beverage$2,18799%
Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	49	$707
Lilly USA, LLC	16	$286
Novo Nordisk	13	$240
Pfizer	9	$156
Abbott	6	$133
Merck	4	$71
Johnson & Johnson	3	$53
Boehringer Ingelheim	3	$51
Exact Sciences	2	$49
Phathom Pharmaceuticals, Inc.	2	$47
Hologic Sales And Service, LLC	3	$42
E.r. Squibb & Sons, L.L.C.	2	$35
Aimmune Therapeutics, Inc.	2	$34
Lundbeck LLC	2	$34
Teva Pharmaceuticals USA, Inc.	1	$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$32
AstraZeneca	2	$29
Daiichi Sankyo Inc.	1	$28
Sanofi-aventis U.S. LLC	1	$27
Otsuka America Pharmaceutical, Inc.	1	$22
Organogenesis Inc.	1	$21
Dexcom, Inc.	1	$20
GSK	1	$18
Currax Pharmaceuticals LLC	1	$15
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

UBRELVY$123

How this compares

$2,199 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	58	$72,905
OzempicSemaglutide	74	$68,504
EliquisApixaban	68	$60,658
TrulicityDulaglutide	53	$59,996
MounjaroTirzepatide	32	$32,020
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	45	$31,080
RybelsusSemaglutide	27	$25,495
XareltoRivaroxaban	55	$25,051
WegovySemaglutide	20	$24,826
LinzessLinaclotide	23	$17,709
MyrbetriqMirabegron	35	$16,679
Breo ElliptaFluticasone/Vilanterol	30	$12,759
Combivent RespimatIpratropium/Albuterol Sulfate	16	$11,273
JanuviaSitagliptin Phosphate	16	$10,138
Aimovig AutoinjectorErenumab-Aooe	14	$9,707

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy	$240	$118,825121 claims
Lilly USA, LLCTrulicity, Mounjaro	$286	$92,01685 claims
Boehringer IngelheimJardiance, Combivent Respimat	$51	$84,17874 claims
PfizerEliquis	$156	$60,65868 claims
GSKTrelegy Ellipta, Breo Ellipta	$18	$43,83975 claims
Johnson & JohnsonXarelto	$53	$25,05155 claims
AbbVieLinzess	$707	$17,70923 claims
MerckJanuvia	$71	$10,13816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Blairsville

Jacqueline KernaghanSpringfield$427K
Drew SodaNew Hope$220K
Angela KapalkoPhiladelphia$123K
Linda PerryPhiladelphia$123K
Cory DavidsonErie$119K
Shelley SassamanTamaqua$90K
Meghan HoffnerBethlehem$86K
Thomas IacovoniDanville$72K
Scott CoxWynnewood$66K
Sarah SmithPhiladelphia$65K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →